Trial intelligence / Profile preview

POGSI intrapartum antibiotic prophylaxis trial for maternal and neonatal Group G/C streptococcal infections

2020-002696-34Phase 4Active

Sponsor
University of Oulu
Start
Jun 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of Benzathine penicillin and clindamycin in streptococcal infection, postpartum infection and neonatal infection (2 arms), sponsored by University of Oulu. Primary endpoint: Postpartum maternal infection requiring antibiotic treatment. Started Jun 2021; status: active.

02

Drugs

Benzathine penicillinclindamycin
03

Conditions

streptococcal infectionpostpartum infectionneonatal infection

Beyond the preview

Go deeper on 2020-002696-34.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-002696-34.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call